By COLUMBIA UNIVERSITY IRVING MEDICAL CENTER: Complete Post through this link…
ngd-How can anyone think that any drug, legal or illegal (including alcohol) could dramatically change the brain’s biochemistry but somehow be entirely without risk???
A first-in-class drug engineered to selectively inhibit the signaling pathway of the cannabinoid receptor holds potential as a safe and efficacious treatment for cannabis use disorder (CUD). CUD is a condition in which an individual struggles to regulate their cannabis consumption, despite it causing issues in their life.
During a Phase 2a clinical trial conducted by Columbia University Irving Medical Center and Aelis Farma, a French biopharmaceutical firm, researchers found that the candidate drug, AEFO117, significantly reduced the effects of cannabis in daily cannabis smokers.
